Page 125 - 中国全科医学2022-09

·1146· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

and activates brown adipose tissue via the gut-brain neural ［42］WU H，ESTEVE E，TREMAROLI V，et al. Metformin alters the
circuit［J］. Gut，2018，67（7）：1269-1279. DOI： gut microbiome of individuals with treatment-naive type 2 diabetes，
10.1136/gutjnl-2017-314050. contributing to the therapeutic effects of the drug［J］. Nat Med，
［30］VOZZA A，PARISI G，DE LEONARDIS F，et al. UCP2 transports 2017，23（7）：850-858. DOI：10.1038/nm.4345.
C4 metabolites out of mitochondria，regulating glucose and ［43］DE LA CUESTA-ZULUAGA J，MUELLER N T，CORRALES-
glutamine oxidation［J］. Proc Natl Acad Sci USA，2014，111（3）： AGUDELO V，et al. Metformin is associated with higher relative
960-965. DOI：10.1073/pnas.1317400111. abundance of mucin-degrading Akkermansia muciniphila and
［31］GAO Z G，YIN J，ZHANG J，et al. Butyrate improves insulin several short-chain fatty acid-producing microbiota in the gut［J］.
sensitivity and increases energy expenditure in mice［J］. Diabetes Care，2017，40（1）：54-62. DOI：10.2337/dc16-
Diabetes，2009，58（7）：1509-1517. DOI：10.2337/db08- 1324.
1637. ［44］BRUNKWALL L，ORHO-MELANDER M. The gut microbiome
［32］HENAGAN T M，STEFANSKA B，FANG Z D，et al. Sodium as a target for prevention and treatment of hyperglycaemia in type 2
butyrate epigenetically modulates high-fat diet-induced skeletal diabetes：from current human evidence to future possibilities［J］.
muscle mitochondrial adaptation，obesity and insulin resistance Diabetologia，2017，60（6）：943-951. DOI：10.1007/s00125-
through nucleosome positioning［J］. Br J Pharmacol，2015，172
017-4278-3.
（11）：2782-2798. DOI：10.1111/bph.13058. ［45］ZHANG X，FANG Z，ZHANG C，et al. Effects of acarbose on
［33］ARAÚJO J R，TAZI A，BURLEN-DEFRANOUX O，et al.
the gut microbiota of prediabetic patients：a randomized，double-
Fermentation products of commensal bacteria alter enterocyte lipid
blind，controlled crossover trial［J］. Diabetes Ther，2017，8（2）：
metabolism［J］. Cell Host Microbe，2020，27（3）：358-375.
293-307. DOI：10.1007/s13300-017-0226-y.
e7. DOI：10.1016/j.chom.2020.01.028.
［46］YAN X F，FENG B，LI P C，et al. Microflora disturbance during
［34］GUI H B，SHEN Z M. Concentrate diet modulation of ruminal genes
progression of glucose intolerance and effect of sitagliptin：an animal
involved in cell proliferation and apoptosis is related to combined
study［J］. J Diabetes Res，2016，2016：2093171. DOI：
effects of short-chain fatty acid and pH in rumen of goats［J］. J
10.1155/2016/2093171.
Dairy Sci，2016，99（8）：6627-6638. DOI：10.3168/jds.2015-
［47］WANG L，LI P，TANG Z，et al. Structural modulation of the
10446.
gut microbiota and the relationship with body weight：compared
［35］ZHAO J B，LIU P，WU Y，et al. Dietary fiber increases butyrate-
evaluation of liraglutide and saxagliptin treatment［J］. Sci Rep，
producing bacteria and improves the growth performance of weaned
2016，6：33251. DOI：10.1038/srep33251.
piglets［J］. J Agric Food Chem，2018，66（30）：7995-8004.
［48］LIAO X Y，SONG L Y，ZENG B H，et al. Alteration of gut
DOI：10.1021/acs.jafc.8b02545.
microbiota induced by DPP-4i treatment improves glucose
［36］FENG Y H，WANG Y，WANG P，et al. Short-chain fatty acids
homeostasis［J］. EBioMedicine，2019，44：665-674. DOI：
manifest stimulative and protective effects on intestinal barrier
10.1016/j.ebiom.2019.03.057.
function through the inhibition of NLRP3 inflammasome and
［49］JAYACHANDRAN M，CHEN J L，CHUNG S S M，et al. A
autophagy［J］. Cell Physiol Biochem，2018，49（1）：190-
critical review on the impacts of β-glucans on gut microbiota and
205. DOI：10.1159/000492853.
human health［J］. J Nutr Biochem，2018，61：101-110. DOI：
［37］FACHI J L，SÉCCA C，RODRIGUES P B，et al. Acetate
10.1016/j.jnutbio.2018.06.010.
coordinates neutrophil and ILC3 responses against C. difficile
through FFAR2［J］. J Exp Med，2020，217（3）：e20190489. ［50］ZHANG C，MA S，WU J，et al. A specific gut microbiota and
metabolomic profiles shifts related to antidiabetic action：The
DOI：10.1084/jem.20190489.
［38］DUSCHA A，GISEVIUS B，HIRSCHBERG S，et al. similar and complementary antidiabetic properties of type 3 resistant
Propionic acid shapes the multiple sclerosis disease course by an starch from Canna edulis and metformin［J］. Pharmacol Res，
immunomodulatory mechanism［J］. Cell，2020，180（6）： 2020，159：104985. DOI：10.1016/j.phrs.2020.104985.
1067-1080.e16. DOI：10.1016/j.cell.2020.02.035. ［51］LIU G，LIANG L，YU G，et al. Pumpkin polysaccharide modifies
［39］RAU M，REHMAN A，DITTRICH M，et al. Fecal SCFAs and the gut microbiota during alleviation of type 2 diabetes in rats［J］.
SCFA-producing bacteria in gut microbiome of human NAFLD Int J Biol Macromol，2018，115：711-717. DOI：10.1016/j.
as a putative link to systemic T-cell activation and advanced ijbiomac.2018.04.127.
disease［J］. United European Gastroenterol J，2018，6（10）： ［52］NIE Q，CHEN H，HU J，et al. Arabinoxylan attenuates type
1496-1507. DOI：10.1177/2050640618804444. 2 diabetes by improvement of carbohydrate，lipid，and amino
［40］KELLY C J，ZHENG L，CAMPBELL E L，et al. Crosstalk between acid metabolism［J］. Mol Nutr Food Res，2018，62（20）：
microbiota-derived short-chain fatty acids and intestinal epithelial e1800222. DOI：10.1002/mnfr.201800222.
HIF augments tissue barrier function［J］. Cell Host Microbe， ［53］ZHAO C，YANG C F，LIU B，et al. Bioactive compounds
2015，17（5）：662-671. DOI：10.1016/j.chom.2015.03.005. from marine macroalgae and their hypoglycemic benefits［J］.
［41］FORSLUND K，HILDEBRAND F，NIELSEN T，et al. Trends Food Sci Technol，2018，72：1-12. DOI：10.1016/j.
Disentangling type 2 diabetes and metformin treatment signatures in tifs.2017.12.001.
the human gut microbiota［J］. Nature，2015，528（7581）： ［54］LIU Y Y，WANG C R，LI J S，et al. Phellinus linteus
262-266. DOI：10.1038/nature15766. polysaccharide extract improves insulin resistance by regulating gut